During the past decade, Mass General North Shore Cancer Center conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 22 clinical trials were completed, i.e. on average, 122.2% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 12 clinical trials were completed. i.e. 171.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mass General North Shore Cancer Center" #1 sponsor was "Massachusetts General Hospital" with 9 trials, followed by "National Cancer Institute (NCI)" with 8 trials sponsored, "Radiation Therapy Oncology Group" with 8 trials sponsored, "Dana-Farber Cancer Institute" with 6 trials sponsored and "Alliance for Clinical Trials in Oncology" with 6 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mass General North Shore Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 19 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator and "Radiation Therapy Oncology Group" with 4 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "Mass General North Shore Cancer Center" are "Breast Cancer" (13 trials), "Prostate Cancer" (4 trials), "Head and Neck Cancer" (3 trials), "Multiple Myeloma" (3 trials) and "Recurrent Breast Carcinoma" (3 trials). Many other conditions were trialed in "Mass General North Shore Cancer Center" in a lesser frequency.

Most popular intervention types in "Mass General North Shore Cancer Center" are "Drug" (35 trials), "Radiation" (17 trials), "Other" (13 trials), "Biological" (9 trials) and "Behavioral" (4 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (9 trials), "Laboratory Biomarker Analysis" (6 trials), "Quality-of-Life Assessment" (6 trials), "Carboplatin" (3 trials) and "Cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Mass General North Shore Cancer Center" are 30 trials for "All" genders, 13 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Mass General North Shore Cancer Center". 1 are not yet recruiting, 6 are recruiting, 20 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Mass General North Shore Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mass General North Shore Cancer Center, 0 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".